Samuel Gershon
Impact in
- Biological Psychiatry top 0.2%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 0.1%
- Bipolar Disorder and Treatment
- Schizophrenia research and treatment
Papers in
-
- Bipolar Disorder and Treatment 75
- Schizophrenia research and treatment 45
- Electroconvulsive Therapy Studies 24
- Attention Deficit Hyperactivity Disorder 18
-
- Neurotransmitter Receptor Influence on Behavior 61
- Neuroscience and Neuropharmacology Research 36
- Co-authors
- Burton Angrist (19 shared papers)Eitan Friedman (29 shared papers)John Rotrosen (29 shared papers)Baron Shopsin (34 shared papers)Michael Stanley (16 shared papers)Gregory Sathananthan (16 shared papers)Steven H. Ferris (12 shared papers)Burt Angrist (8 shared papers)
- Journals
- Psychopharmacology (30 papers)Bipolar Disorders (24 papers)Life Sciences (23 papers)European Journal of Pharmacology (13 papers)Journal of Clinical Psychopharmacology (9 papers)
- Partner nations
- United StatesAustraliaIsrael
In The Last Decade
Samuel Gershon
368 papers receiving 10.4k citations
Samuel Gershon's Hit Papers
Peers
Comparison fields: 5 of 174
- Biological Psychiatry 864
- Psychiatry and Mental health 4.5k
- Cellular and Molecular Neuroscience 3.7k
- Behavioral Neuroscience 649
- Pharmacology 1.9k
Countries citing papers authored by Samuel Gershon
This map shows the geographic impact of Samuel Gershon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Gershon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Gershon more than expected).
Fields of papers citing papers by Samuel Gershon
This network shows the impact of papers produced by Samuel Gershon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Gershon. The network helps show where Samuel Gershon may publish in the future.
Co-authors
The 25 scholars most cited alongside Samuel Gershon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 384 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Age‐associated memory impairment: Proposed diagnostic criteria and measures of clinical change — report of a national institute of mental health work group Hit paper breakdown → | 1986 | 701 |
| 2 | 1982 | 373 | |
| 3 | The phenomenology of experimentally induced amphetamine psychosis--preliminary observations. | 1970 | 344 |
| 4 | 1993 | 288 | |
| 5 | 1980 | 281 | |
| 6 | 1961 | 249 | |
| 7 | 1974 | 245 | |
| 8 | 1961 | 232 | |
| 9 | 2000 | 182 | |
| 10 | 1992 | 159 | |
| 11 | 1990 | 151 | |
| 12 | 1955 | 124 | |
| 13 | 1983 | 119 | |
| 14 | 1971 | 117 | |
| 15 | Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients. | 1975 | 116 |
| 16 | 2004 | 113 | |
| 17 | 1980 | 112 | |
| 18 | 1968 | 112 | |
| 19 | 1980 | 103 | |
| 20 | Psychopathology and brain dysfunction | 1977 | 101 |
About Samuel Gershon
Samuel Gershon is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience, Pharmacology, Molecular Biology and Physiology, having authored 384 papers that have together received 11.6k indexed citations. Recurring topics across this work include Bipolar Disorder and Treatment (75 papers), Neurotransmitter Receptor Influence on Behavior (61 papers), Treatment of Major Depression (46 papers), Schizophrenia research and treatment (45 papers), Neuroscience and Neuropharmacology Research (36 papers), Electroconvulsive Therapy Studies (24 papers), Stress Responses and Cortisol (19 papers) and Attention Deficit Hyperactivity Disorder (18 papers). The work is most often cited by research in Biological Psychiatry (864 citations), Psychiatry and Mental health (4.5k citations), Cellular and Molecular Neuroscience (3.7k citations), Behavioral Neuroscience (649 citations) and Pharmacology (1.9k citations). Samuel Gershon has collaborated with scholars based in United States, Australia and Israel. Frequent co-authors include Burton Angrist, Eitan Friedman, John Rotrosen, Baron Shopsin, Michael Stanley, Gregory Sathananthan, Steven H. Ferris, Burt Angrist, A. S. Brown and Joseph Levine. Their work appears in journals such as Psychopharmacology, Bipolar Disorders, Life Sciences, European Journal of Pharmacology and Journal of Clinical Psychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.